Arrowhead Pharmaceuticals Inc (ARWR)
SBC to Revenue
19.57%
Quarterly · Period ending:
ARWR SBC to Revenue
Latest reported19.57%period ending
Latest reported19.57%period ending
ARWR Quarterly SBC/Revenue (0.00% → 19.57%)
Latest values, visible window
High-resolution chart · PNG
ARWR sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 19.5713% | |
| 22.8027% | |
| 7.3366% | |
| 7.4421% | |
| 46.973% | |
| 2.9531% | |
| 608.36% | |
| 0% | |
| 0% | |
| 0% | |
| 554.6043% | |
| 112.9465% | |
| 126.0474% | |
| 14.092% | |
| 31.0012% | |
| 92.4656% | |
| 103.0174% | |
| 22.2674% | |
| 89.3035% | |
| 90.437% | |
| 40.4197% | |
| 46.8075% | |
| 38.2294% | |
| 207.9605% | |
| 36.6964% | |
| 55.132% | |
| 15.2504% | |
| 11.8183% | |
| 4.5858% | |
| 5.4028% | |
| 7.841% | |
| 23.425% | |
| 311.9113% | |
| 224.082% | |
| 59.6196% | |
| 23.0634% | |
| 18.338% | |
| 19.4107% | |
| 55.5365% | |
| 12,953.1168% | |
| 6,949.4101% | |
| 5,524.2034% | |
| 5,440.784% | |
| 8,061.4583% | |
| 2,008.9487% | |
| 5,040.1806% | |
| 1,180.0035% | |
| 4,429.5063% | |
| 4,659.8446% | |
| 2,739.3006% | |
| 1,191.1726% | |
| 964.3337% | |
| 831.0697% | |
| 811.6731% | |
| 248.8272% | |
| 923.9223% | |
| 868.0009% | |
| 542.048% | |
| 1,051.3315% | |
| 0% | |
| 0% | |
| 0% | |
| 124.9913% | |
| 300.3929% | |
| 0% | |
| 5.0877% | |
| 204.009% | |
| 344.2535% | |
| 21.0984% | |
| 295.0456% | |
| 103.7352% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |